Sign inJoin waitlistJoin the waitlist

Pamela Egan

Assistant Professor of Medicine, Tufts University School of Medicine · MaineHealth

Credentials: · · · · ·

History

MaineHealth
Present

Hematology and Medical Oncology
Rhode Island Hospital/Brown University Health
2015–2018
Internal Medicine
Rhode Island Hospital/Brown University Health
2012–2015
SUNY Upstate Medical University Coll of Med
2008–2012

Research

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1,345 citations
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Cancer Discovery · 2020 · 111 citations
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia
Blood · 2018 · 83 citations

Adam Olszewski
11 papers
Jeremy Warner
6 papers
Dimitrios Farmakiotis
5 papers
John Reagan
5 papers
AP
Ari Pelcovits
4 papers · 3 as a fellow
Gary Lyman
4 papers
Petros Grivas
4 papers
Rana McKay
4 papers
Tom LeBlanc
4 papers
Brian Rini
3 papers
Chinmay Jani
3 papers
Clara Hwang
3 papers

Clinical trials

Removing Transfusion Dependence as a Barrier to Hospice Enrollment
Principal investigator · Completed
Adam Olszewski
2021–2023
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027